Drug shortages in Germany ‒ A critical appraisal

Drug shortages in Germany ‒ A critical appraisal

Together with the two Managing Partners of the Entourage, Dominik M. Aumer and Moritz Haucke, our Management Consultants Dr. Ralf Hess and Dr. Simon Schulz have published an article about the drug shortage and its causes in the Regulatory Affairs Professionals Society.

From the perspective of a medium-sized manufacturer of generic drugs, the article analyses the causes of the shortage of drugs in Germany and the causes of production problems at active ingredient and drug manufacturers. Measures to limit the damage on a “broken marketplace” are discussed and an epilogue is given to the current COVID 19 pandemic, warning that drugs and active ingredients from China and India could become scarce due to the disruptions caused by the pandemic.

Under the following link you can find the article.

read here.